Therapy Areas: Inflammatory Diseases
Europe's drug regulator lists new side-effect of J&J's COVID-19 vaccine
11 November 2021 -

The European Medicines Agency (EMA), Europe's drug regulator, has recommended the addition of a rare type of spinal inflammation as a side-effect of US pharmaceutical company Johnson & Johnson's (NYSE:JNJ) COVID-19 vaccine, Reuters news agency reported on Thursday.

The EMA said its was also assessing reports of capillary leak syndrome following inoculation with Moderna's (Nasdaq:MRNA) COVID-19 vaccine.

According to the EMA, there is currently not enough evidence of a possible link between rare cases of multisystem inflammatory syndrome with mRNA vaccines, including Moderna's shot.



Related Headlines